Solid Biosciences (SLDB) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 27, 2026

Net selling: insiders sold $25K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: -$25K netNet selling
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 2 added, 0 cutMore adding
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about SLDB filings

Are insiders buying or selling Solid Biosciences LLC (SLDB) stock?

Net selling: insiders sold $25K and bought $0 of SLDB stock on the open market in the 90 days to Oct 27, 2026, according to SEC Form 4 filings. $25K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Brooks, Gabriel (Chief Medical Officer), who sold $25K. The latest filing was on Oct 20, 2026.

Which members of Congress have traded SLDB recently?

None. No member of Congress disclosed a SLDB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SLDB smart-money data?

This summary uses filings available on Oct 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on SLDB

Lean long1 source:
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Gabriel Brooks, sold $24.6K, scheduled plan sale, filed Oct 20
Lean short · thin1 sale · $24.6K
1 of 1 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
Lean long3 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about SLDB filings

Are insiders buying or selling Solid Biosciences LLC (SLDB) stock?

Which members of Congress have traded SLDB recently?

None. No member of Congress disclosed a SLDB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this SLDB smart-money data?

Funds

What funds are doing

3 moves · 6 mo

Buys/Adds$90.9M

Buys/Adds (3)

FM
FMR LLC
Q2 2026 13F
$42.7M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
SS
State Street
Q2 2026 13F
$33.6M
added
FM
FMR LLC
Q1 2026 13F
$14.5M
added

Reported Aug 6, 2026

Earnings came in 18.9% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.38+18.86% beat

-$0.47 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

Estimated report: Nov 2, 2026, in 6 days

Previous reports

Period ending	Reported	EPS / estimate	EPS surprise	Revenue / income	Surprise
Jun 30, 2026	Aug 6, 2026	-$0.38 / -$0.47Yahoo Finance	+18.86% beat	$0.00 No estimate	Unavailable
Dec 31, 2025	Mar 19, 2026	-$0.53 / -$0.52Yahoo Finance	-1.85% miss	$0.00 No estimate	Unavailable
Sep 30, 2025	Nov 3, 2025	-$0.48 / -$0.44Yahoo Finance	-8.92% miss	$0.00 No estimate	Unavailable
Dec 31, 2022	Mar 23, 2023	Unavailable	-	$8.1M No estimateYear ended Dec 31, 2022 · SEC filing	Unavailable
Sep 30, 2020	Nov 5, 2020	Unavailable	-	$0.00 No estimateSEC filing	Unavailable
Jun 30, 2020	Aug 6, 2020	Unavailable	-	$0.00 No estimateSEC filing	Unavailable
Mar 31, 2020	May 7, 2020	Unavailable	-	$0.00 No estimateSEC filing	Unavailable
Dec 31, 2019	Mar 12, 2020	Unavailable	-	$0.00 No estimateSEC filing	Unavailable

EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.

Open: $6.12
52-wk high: $11.45
High: $6.23
52-wk low: $3.79
Low: $5.78
Prev close: $6.19
Mkt cap: $634.8M
ROE: -65.5%
Beta: 2.47
P/S: 3.6x
P/B: 1.7x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $635M

Valuation

P/S3.65
P/B1.73

Quality

Operating margin0.0%
ROE-65.5%
ROA-36.4%

Growth

Beta2.47

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

34balanced

20D volatility

76%annualized

52-week range

$5.92

$3.79$11.45

20D support

$5.38recent floor

20D resistance

$7.54recent ceiling

Returns

5D +7.1%20D -18.8%60D -30.3%

Price vs moving averages

SMA20 -9.0%SMA50 -27.1%SMA200 -22.5%

Volume pace

1.18xvs prior 20D

Period ending

Reported

EPS / estimate

EPS surprise

Revenue / income

Surprise

Jun 30, 2026

Aug 6, 2026

-$0.38 / -$0.47Yahoo Finance

+18.86% beat

$0.00 No estimate

Unavailable

Dec 31, 2025

Mar 19, 2026

-$0.53 / -$0.52Yahoo Finance

-1.85% miss

$0.00 No estimate

Unavailable

Sep 30, 2025

Nov 3, 2025

-$0.48 / -$0.44Yahoo Finance

-8.92% miss

$0.00 No estimate

Unavailable

Dec 31, 2022

Mar 23, 2023

Unavailable

$8.1M No estimateYear ended Dec 31, 2022 · SEC filing

Unavailable

Sep 30, 2020

Nov 5, 2020

Unavailable

$0.00 No estimateSEC filing

Unavailable

Jun 30, 2020

Aug 6, 2020

Unavailable

$0.00 No estimateSEC filing

Unavailable

Mar 31, 2020

May 7, 2020

Unavailable

$0.00 No estimateSEC filing

Unavailable

Dec 31, 2019

Mar 12, 2020

Unavailable

$0.00 No estimateSEC filing

Unavailable

Solid Biosciences LLC

Smart money at a glance

What do analysts expect?

Questions about SLDB filings

Smart money on SLDB

Questions about SLDB filings

What funds are doing

What insiders are doing

How top traders are positioned

Earnings came in 18.9% above what analysts expected.

Estimated report: Nov 2, 2026, in 6 days

Previous reports

Is the business strong?

Price structure

Solid Biosciences LLC

Smart money at a glance

What do analysts expect?

Questions about SLDB filings

Smart money on SLDB

Questions about SLDB filings

What funds are doing

What insiders are doing

How top traders are positioned

Earnings came in 18.9% above what analysts expected.

Estimated report: Nov 2, 2026, in 6 days

Previous reports

Is the business strong?

Price structure

Solid Biosciences LLC

Overview

Questions about SLDB filings

Smart money

Smart money on SLDB

Questions about SLDB filings

Earnings

Financials

Technicals

Solid Biosciences LLC

Overview

Questions about SLDB filings

Smart money

Smart money on SLDB

Questions about SLDB filings

Earnings

Financials

Technicals